Company KPI Data Charting Tools Stock Screener Industry Financials Time Series Tables

Login Start for Free

My Subscriptions My Account My Orders Log Out

Research Tools

Company KPI Data
Charting Tools
Stock Screener
Industry Financials
Time Series Tables

Login Start for Free

Overview
Financial Statements
KPIs & Operating Metrics
Estimates
Peers
Ownership
- Institutional Ownership
- Insider Ownership
SEC Filings
Charts

Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Liabilities and Shareholders Equity Non-Current Assets Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Retained Earnings Shareholder's Equity Shares Outstanding Short-term Investments Total Current Liabilities Total Liabilities Total Non-Current Liabilities

Cash Flow Statement

Amortization of Deferred Charges Amortizatization of Intangibles Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Accured Expenses Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Depreciation and Depletion Free Cash Flow Gains from Investment Securities Net Cash Flow Net Income Non-cash Items Share-based Compensation Shares Issued

Daily Values

DMA 100 DMA 200 DMA 50 EV to CFO EV to EBIT EV to EBITDA EV to FCF EV to Revenue Price Price to Earnings

Growth Metrics

EBIT Margin (QoQ)EBITDA Margin (QoQ)EBT Margin (QoQ)Enterprise Value (QoQ)FCF Margin (QoQ)Net Margin (QoQ)Operating Margin (QoQ)Return on Assets (QoQ)Return on Capital Employed (QoQ)Return on Equity (QoQ)Return on Sales (QoQ)Return on Sales Growth (1y)

Income Statement

Consolidated Net Income EBIT EBITDA EBT EPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing Operations Income towards Parent Company Net Income towards Common Stockholders Non Operating Income Operating Expenses Operating Income Other Non Operating Income Profit After Tax Research & Development Revenue Selling, General & Administrative Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other

Others

Accumulated Depreciation & Amortization Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Receivables - Other

Ratios

Asset Utilization Ratio Assets Average EBIT Margin EBITDA Margin EBT Margin Enterprise Value Equity Average Equity Ratio FCF Margin Invested Capital Net Margin Operating Margin Return on Assets Return on Capital Employed Return on Equity Return on Sales

Design Therapeutics (DSGN) Leases (2021)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Design Therapeutics' Leases history spans 1 years, with the latest figure at $3.7 million for Q3 2021.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value

×

Your powerful stock research platform

Resources

About Us
Sitemap
Contact Us

Company

Terms of Use
Privacy Policy
Plans & Pricing
Schedule a Demo

Create an account

Start your journey with us today. It's free!

I agree to the privacy policy.

Have an account already? Sign In

Sign In

Welcome back! Please enter your details.

Remember Me

Forgot Password?

Don't have an account? Create one now

Reset Password

Enter your email to receive a reset link.

Back to Sign In

Get Pro for 60% off

Access all features immediately
Segment financials and operating data
Export data in CSV and XLSX formats

Offer Ends In

00Days

00Hours

00Minutes

00Seconds

Starting from ~~$49~~ $19 / month

Claim Discount